Curia Expands Fermentation Capacity in León, Spain

Albany, NY- November 9, 2026 - Curia Global Inc. (Curia), a global contract research, development and manufacturing organization (CDMO), today announced the completion of its 5-million-euro investment in its León, Spain operations. The project supports a new precision fermentation facility for development and scale-up activities through capacity enablement and upgraded site utilities.

As part of the initiative, Curia built a facility with fermentation (USP) and downstream processing (DSP) equipment to enable optimized manufacturing flows. To fully support the new production building, the project includes the installation of critical utility systems. These upgrades are designed to provide a reliable utility supply across production operations. New equipment installations will increase the facility's capacity to 58,000 L.

"Curia is committed to supporting customers with reliable, efficient manufacturing and flexible capacity as programs advance," said Jamie Grabowski, President of R&D at Curia. "By aligning our equipment footprint and upgrading essential utilities, we are building a strong foundation for sustained performance at León."

Curia's León facility specializes in biotechnology development, fermentation production and downstream processing for customers across the pharmaceutical, cosmetic, agriculture and food industries. This expansion reflects Curia's continued focus on strengthening its manufacturing network and ensuring that sites are equipped to meet evolving customer needs through dependable operations and high standards of quality.

About Curia

Curia is a contract research, development and manufacturing organization (CDMO) with over 30 years of experience, an integrated network of 20+ global sites and 3,100 employees partnering with biopharmaceutical customers to bring life-changing therapies to market. Our offerings in small molecule, generic APIs and biologics span discovery through commercialization, with integrated regulatory, analytical and sterile fill-finish capabilities. Our scientific and process experts, along with our regulatory-compliant facilities, provide a best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate your research and improve patients' lives. Visit us at curiaglobal.com.